Conscious Sedation Report
Conscious Sedation Report
Objectives of Conscious-Sedation
Spectrum of Pain Control
1. The patient’s mood must be altered- to eliminate fear
and apprehension which thereby aid in control of pain
reaction.
PARENTERAL ADMINISTRATION
• This is done after the dentist selected and Intravenous, intramuscular and subcutaneous
chosen the drugs and techniques of are most frequently used
administration best suited to his needs. Require minimum amount of equipment and
skills
1. The conscious-sedation procedure should be Mastered easily
explained briefly and concisely.
2. Patient should be instructed to wear 1. Intravenous administration
comfortable, loose fitting garments. - Most reliable (in line with inhalation
3. Patient is instructed to eat a light liquid meal no route)
- Rapid effect
less than 2 to 3 hours before the scheduled
- Dose accurately controlled
treatment.
- Dentist administers small incremental
4. Those patient who will be receiving nitrous oxide
doses while observing patient, titrates
and oxygen alone must be told that they will
small drug increments to produce
have to be escorted from the office by a
desired effect.
responsible adult.
- Dose is quantum sufficit
- Drugs have predictable duration
- Circumvents the disadvantage of
ROUTES OF ADMINISTRATION inhalation route – the lack of potent
agents
1. Inhalation - Safe / safer than oral or other parenteral
- Dependable, convenient routes
- Rapid onset - Patient acceptance is good
- Short recovery period - A patient who usually objects to an
- Effects may be rapidly reversed by injection in the oral cavity will willingly
Lowering concentration of agent consent to an intravenous injection.
Discontinuation and 2. Venipuncture technique
administration of only oxygen or - Every dentist should acquire a degree of
room air skill in performing this technique
- Disadvantage - Importance:
Most commonly used agent is a) For obtaining maximum
the weakest agent available effectiveness of drugs
- Nitrous Oxide b) Most advantageous in
emergency situations
[Type text]
GENERIC
BRANDNAME
NAME
CHLORPROMA
THORAZINE
ZINE
DIMETHYL
PSYCHOSEDATIVE DRUGS AMINE
PROMAZINE SPARINE
• Classified under CNS depressant drugs THIFLUPROMA
• are specifically given to patients with psychiatric PHENOTHIA VESPRIN
ZINE
ZINES
disorders:
• Ex. Psychosis (schizophrenia), PERPHENAZIN PERPHENAZIN
E E
Neuroses, Psycho-somatic Disorders PIPERAZIN
and Personality Disorders E
PROCHLORPE PROCHLORPE
• the cerebral cortex is not significantly RAZINE RAZINE
depressed, leading to the belief that the reticular MEPROBAMAT
system is depressed to prevent excessive EQUANIL
E
PROPYL ALCOHOL
stimulation of the cerebral cortex. DERIVATIVES
PHENAGLYCO
• excessive doses will not bring about drowsiness,
DOL
lethargy or sleep unlike barbiturates, narcotics
LORAZEPAM ATIVAN
POTENTIATION:
CHLORDIAZPO
- When combined with narcotics or barbiturates, XIDE
LIBRIUM
BENZODIAZEPINE
psychosedatives produce a greater sedative effect.
- Doses of each drug should be reduced when used DIAZEPAM VALIUM
together. OXAZDEPAM SERAX
EFFECTS OF MORPHINE
1. ANALGESIA & SEDATION CONCLUSION:
- can alter the suffering component of pain - Narcotics will remain the premier drug for
resulting in indifference to the experience. conscious sedation since intense analgesia is
- This coupled with the analgesia makes the not as important in conscious sedation as
patient unlikely to react to or perceive pain. euphoria, reduction of anxiety and freedom from
2. EUPHORIA fear are.
3. MEDULLARY RESPIRATORY AND
CARDIOVASCULAR DEPRESSION SEDATION WITH USE OF MULTIPLE AGENTS
- Dose-dependent - Drugs for conscious sedation may be given in
4. CEREBRAL VASODILATION combinations and/or through different routes of
administration to produce a myriad of effects.
OTHER EFFECTS: - These combinations must be made in line with
5. MIOSIS concepts of spectrum of pain control, techniques
- Pin-point constriction of the pupils of conscious sedation, spectrum of medication,
6. VOMITING doses and routes of administration.
- Usually on the first dose only. Succeeding doses
produce anti-emesis.
ROUTES OF ADMINISTRATION:
- Intravenous
- Intramuscular
- Subcutaneous
BIOTRANSFORMATION – liver
EXCRETION – kidneys
- As MONOGLUCONORIDE
AGONIST/ANTAGONIST OPIOIDS
- A new category of pharmaceutical agents whose
goal is to isolate the desirable effects of
narcotics while eliminating the harmful effects.
- they have the ability to stimulate certain opioid
receptors while antagonizing others that produce
harmful effects to the body.